Alan D. Friedman

8.3k total citations · 2 hit papers
128 papers, 7.0k citations indexed

About

Alan D. Friedman is a scholar working on Molecular Biology, Hematology and Immunology. According to data from OpenAlex, Alan D. Friedman has authored 128 papers receiving a total of 7.0k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Molecular Biology, 56 papers in Hematology and 38 papers in Immunology. Recurrent topics in Alan D. Friedman's work include Acute Myeloid Leukemia Research (55 papers), Immune Response and Inflammation (17 papers) and Immune cells in cancer (16 papers). Alan D. Friedman is often cited by papers focused on Acute Myeloid Leukemia Research (55 papers), Immune Response and Inflammation (17 papers) and Immune cells in cancer (16 papers). Alan D. Friedman collaborates with scholars based in United States, Italy and China. Alan D. Friedman's co-authors include Steven L. McKnight, Robert M. Umek, William Landschulz, Tanawan Kummalue, Hong Guo, Issarang Nuchprayoon, Joseph Suzow, Qian-Fei Wang, Ido Paz‐Priel and Scott W. Hiebert and has published in prestigious journals such as Science, Journal of Biological Chemistry and Genes & Development.

In The Last Decade

Alan D. Friedman

127 papers receiving 6.9k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

CCAAT-Enhancer Binding Protein: A Component of a Differentiation Switch

1991 648 citations Alan D. Friedman et al. profile →
Differentiation-induced gene expression in 3T3-L1 preadipocytes: CCAAT/enhancer binding protein interacts with and activates the promoters of two adipocyte-specific genes.

1989 531 citations Alan D. Friedman et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Alan D. Friedman	4.4k	2.1k	1.7k	1.0k	819	128	7.0k
Claus Nerlov	5.1k 1.2×	2.9k 1.4×	2.7k 1.5×	1.1k 1.1×	1.1k 1.3×	105	8.8k
Reuben Kapur	2.8k 0.6×	1.3k 0.7×	2.4k 1.4×	932 0.9×	568 0.7×	172	6.0k
Louis M. Pelus	2.5k 0.6×	2.0k 1.0×	2.3k 1.3×	1.8k 1.8×	523 0.6×	159	6.3k
Marieke Essers	2.8k 0.6×	1.6k 0.8×	1.5k 0.9×	803 0.8×	498 0.6×	43	5.0k
William Blanco-Bose	2.3k 0.5×	1.7k 0.8×	1.3k 0.7×	674 0.7×	376 0.5×	22	4.8k
Cornelius Miething	3.0k 0.7×	863 0.4×	1.2k 0.7×	1.5k 1.5×	740 0.9×	68	5.1k
T Sudo	2.9k 0.7×	739 0.4×	2.1k 1.2×	1.1k 1.1×	517 0.6×	80	5.6k
Kenji Oritani	2.3k 0.5×	980 0.5×	2.4k 1.4×	1.4k 1.4×	562 0.7×	177	6.3k
Wei Tong	2.7k 0.6×	1.7k 0.8×	1.1k 0.7×	948 0.9×	576 0.7×	84	5.6k
Noboru Motoyama	5.1k 1.2×	497 0.2×	1.8k 1.1×	1.8k 1.8×	1.1k 1.4×	63	7.6k

Countries citing papers authored by Alan D. Friedman

Since Specialization

Citations

This map shows the geographic impact of Alan D. Friedman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan D. Friedman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan D. Friedman more than expected).

Fields of papers citing papers by Alan D. Friedman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan D. Friedman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan D. Friedman. The network helps show where Alan D. Friedman may publish in the future.

Co-authorship network of co-authors of Alan D. Friedman

This figure shows the co-authorship network connecting the top 25 collaborators of Alan D. Friedman. A scholar is included among the top collaborators of Alan D. Friedman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan D. Friedman. Alan D. Friedman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Barberi, Theresa J., et al.. (2025). PSMA antibody, humanized PSMA.CAR10.3, or Cetuximab increases prostate cancer localization of NF-κB p50-deficient immature myeloid cells (p50-IMC) and phagocytosis by their macrophage progeny. Cancer Immunology Immunotherapy. 74(3). 95–95.

Barberi, Theresa J. & Alan D. Friedman. (2023). 344 Human macrophages lacking NF-κB p50 display increased proinflammatory cytokine expression. SHILAP Revista de lepidopterología. A393–A393. 1 indexed citations

Peng, Lei, Hong Guo-Parke, Peilin Ma, et al.. (2019). HoxA9 binds and represses the Cebpa +8 kb enhancer. PLoS ONE. 14(5). e0217604–e0217604. 4 indexed citations

Zimmerlin, Ludovic, Tea Soon Park, Jeffrey S. Huo, et al.. (2016). Tankyrase inhibition promotes a stable human naïve pluripotent state with improved functionality. Development. 143(23). 4368–4380. 62 indexed citations

Zhang, Jing, Li Li, Albert S. Baldwin, Alan D. Friedman, & Ido Paz‐Priel. (2015). Loss of IKKβ but Not NF-κB p65 Skews Differentiation towards Myeloid over Erythroid Commitment and Increases Myeloid Progenitor Self-Renewal and Functional Long-Term Hematopoietic Stem Cells. PLoS ONE. 10(6). e0130441–e0130441. 17 indexed citations

Paz‐Priel, Ido, et al.. (2011). C/EBPα, C/EBPα Oncoproteins, or C/EBPβ Preferentially Bind NF-κB p50 Compared with p65, Focusing Therapeutic Targeting on the C/EBP:p50 Interaction. Molecular Cancer Research. 9(10). 1395–1405. 17 indexed citations

Wang, Dehua, Ido Paz‐Priel, & Alan D. Friedman. (2009). NF-κB p50 Regulates C/EBPα Expression and Inflammatory Cytokine-Induced Neutrophil Production. The Journal of Immunology. 182(9). 5757–5762. 58 indexed citations

Sofer, Mario, Avi Beri, Alan D. Friedman, et al.. (2007). Extending the Application of Tubeless Percutaneous Nephrolithotomy. Urology. 70(3). 412–416. 33 indexed citations

Yu, Xiaobing, Jonathan K. Alder, Jong Ho Chun, et al.. (2006). HES1 Inhibits Cycling of Hematopoietic Progenitor Cells via DNA Binding. Stem Cells. 24(4). 876–888. 93 indexed citations

10.

Yang, Yandan, et al.. (2002). c-Myc Overcomes Cell Cycle Inhibition by CBFβ-SMMHC. Cancer Biology & Therapy. 1(5). 492–496. 11 indexed citations

11.

Yang, Yandan, et al.. (2002). TEL-AML1, expressed from t(12;21) in human acute lymphocytic leukemia, induces acute leukemia in mice.. PubMed. 62(14). 3904–8. 75 indexed citations

12.

Kummalue, Tanawan, et al.. (2002). Multimerization via Its Myosin Domain Facilitates Nuclear Localization and Inhibition of Core Binding Factor (CBF) Activities by the CBFβ-Smooth Muscle Myosin Heavy Chain Myeloid Leukemia Oncoprotein. Molecular and Cellular Biology. 22(23). 8278–8291. 24 indexed citations

13.

Cao, Wangsen, et al.. (2000). Exogenous cdk4 overcomes reducedcdk4 RNA and inhibition of G1 progression in hematopoietic cells expressing a dominant-negative CBF – a model for overcoming inhibition of proliferation by CBF oncoproteins. Oncogene. 19(22). 2695–2703. 50 indexed citations

14.

Nuchprayoon, Issarang, et al.. (1999). An Enhancer Located between the Neutrophil Elastase and Proteinase 3 Promoters Is Activated by Sp1 and an Ets Factor. Journal of Biological Chemistry. 274(2). 1085–1091. 33 indexed citations

15.

Petrovick, Martha, Scott W. Hiebert, Alan D. Friedman, et al.. (1998). Multiple Functional Domains of AML1: PU.1 and C/EBPα Synergize with Different Regions of AML1. Molecular and Cellular Biology. 18(7). 3915–3925. 192 indexed citations

16.

Friedman, Alan D., et al.. (1997). Core Binding Factor Cannot Synergistically Activate the Myeloperoxidase Proximal Enhancer in Immature Myeloid Cells without c-Myb. Molecular and Cellular Biology. 17(9). 5127–5135. 81 indexed citations

17.

Lira, Sérgio A. & Alan D. Friedman. (1997). The myeloperoxidase gene proximal enhancer directs hematopoietic-specific expression in transgenic mice. Gene. 197(1-2). 311–314. 1 indexed citations

18.

Oelgeschläger, Michael, Issarang Nuchprayoon, Bernhard Lüscher, & Alan D. Friedman. (1996). C/EBP, c-Myb, and PU.1 Cooperate To Regulate the Neutrophil Elastase Promoter. Molecular and Cellular Biology. 16(9). 4717–4725. 207 indexed citations

19.

Friedman, Alan D., et al.. (1996). The murine myeloperoxidase gene contains a bipartite distal enhancer, including a novel region regulated by PEBP2/CBF. Leukemia Research. 20(10). 809–815. 11 indexed citations

20.

Nuchprayoon, Issarang, Shari Meyers, Linda M. Scott, et al.. (1994). PEBP2/CBF, the Murine Homolog of the Human Myeloid AML1 and PEBP2β/CBFβ Proto-oncoproteins, Regulates the Murine Myeloperoxidase and Neutrophil Elastase Genes in Immature Myeloid Cells. Molecular and Cellular Biology. 14(8). 5558–5568. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact